Back to News
Market Impact: 0.65

Oura ring maker raising $875M Series E, bringing valuation to $11B, report says

Private Markets & VentureCompany FundamentalsCorporate EarningsCorporate Guidance & OutlookTechnology & InnovationConsumer Demand & Retail

Oura Health Oy is reportedly securing $875 million in a Series E financing round, valuing the health and fitness ring maker at approximately $10.9 billion, a significant increase from its $5 billion Series D valuation last December. The company has sold 5.5 million rings and projects revenue to exceed $1 billion in 2025, doubling its 2024 figure, with forecasts for over $1.5 billion in 2026, driven by strong growth among female consumers, retail sales, and international expansion. The new capital will be deployed to scale production, expand globally, and accelerate product development.

Analysis

Oura Health Oy is demonstrating significant growth momentum and investor confidence, evidenced by its reported Series E financing round of $875 million at a $10.9 billion valuation. This valuation represents a doubling from its Series D round just a year prior, a rapid appreciation underpinned by strong operational performance. The company's unit sales have more than doubled since June 2024, reaching 5.5 million rings, which directly supports its aggressive financial projections. Oura anticipates doubling its revenue to over $1 billion in the current year from $500 million in 2024, with a further forecast for sales to exceed $1.5 billion in 2026. This growth trajectory is fueled by a multi-pronged strategy that includes successful expansion into international markets, increased retail store presence, leveraging health savings accounts for purchases, and strong adoption among female consumers. The deployment of the new capital towards scaling production and product development is a logical step to sustain this high-growth phase.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo